🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 78 (from laksa063)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa078.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.tradingview.com/symbols/MYX-PHARMA/\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.tradingview.com/symbols/MYX-PHARMA/\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/","crawl_time":1768815824,"first_indexed_time":1573838165,"http_code":200,"src_unparsed":"com,tradingview!www,\/symbols\/MYX-PHARMA\/ s443","src_root_hash":"6550570140545720678","history_drop_reason":null,"meta_title":"PHARMA Stock Price and Chart — MYX:PHARMA — TradingView","meta_descriptions":["View live Pharmaniaga Bhd. chart to track its stock's price action. Find market predictions, PHARMA financials and market news."],"attrs_boilerpipe_text":"\nFull chart\nUpcoming\nearnings\n\n\nNext report date\n≈\nFebruary 26\nReport period\nQ4 2025\nEPS estimate\n—\nRevenue estimate\n—\nKey\nstats\n\n\nMarket capitalization\n‪1.93 B‬ \nMYR\nDividend yield (indicated)\n—\nPrice to earnings Ratio (TTM)\n16.760\nBasic EPS (TTM)\n0.020 \nMYR\nNet income (FY)\n‪131.82 M‬ \nMYR\nRevenue (FY)\n‪3.76 B‬ \nMYR\nShares float\n‪3.02 B‬\nBeta (1Y)\n2.74\nEmployees\n\n\nEmployees (FY)\n‪3.5 K‬\nChange (1Y)\n+26 +0.75%\nRevenue \/ Employee (1Y)\n‪1.07 M‬ \nMYR\nNet income \/ Employee (1Y)\n‪37.64 K‬ \nMYR\nAbout Pharmaniaga Bhd.\n\nSector\nDistribution Services\nIndustry\nMedical Distributors\nCEO\nZulkifli bin Jafar\nWebsite\npharmaniaga.com\nHeadquarters\nShah Alam\nFounded\n1994\nIdentifiers\n2\nISIN MYL7081OO002\nPharmaniaga Bhd. is as an investment holding company that engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. It operates through the following segments: Pharmaceutical Manufacturing, Pharmaceutical Trading, Marketing Distribution and E-Services, Medical Products and Services, and Others. The Pharmaceutical Manufacturing segment engages in manufacturing of pharmaceutical products. The Marketing Distribution and E-Services segment engages in purchasing, storage, distribution and marketing of pharmaceutical and medical products. The Medical Products and Services segment engages in supply and installation of medical and hospital equipment. The Others segment engages in investment holding. The company was founded in 1994 and is headquartered in Shah Alam, Malaysia.\nFinancials\n\n\nPerformance\n‪0.25%‬\n‪2.75%‬\n‪5.25%‬\n‪7.75%‬\n‪10.25%‬\nQ3 '24\nQ4 '24\nQ1 '25\nQ2 '25\nQ3 '25\n‪0.00‬\n‪‪300.00 M‬‬\n‪‪600.00 M‬‬\n‪‪900.00 M‬‬\n‪‪1.20 B‬‬\nRevenue\nNet income\nNet margin %\nRevenue to profit\nconversion\nRevenue\nCOGS\nGross profit\nOp expenses\nOp income\nNon-Op income\/ expenses\nTaxes & Other\nNet income\n‪0.00‬\n‪‪260.00 M‬‬\n‪‪520.00 M‬‬\n‪‪780.00 M‬‬\n‪‪1.04 B‬‬\nRevenue\nCOGS\nGross profit\nExpenses & adjustments\nNet income\n‪0.00‬\n‪‪260.00 M‬‬\n‪‪520.00 M‬‬\n‪‪780.00 M‬‬\n‪‪1.04 B‬‬\nDebt level and\ncoverage\nQ3 '24\nQ4 '24\nQ1 '25\nQ2 '25\nQ3 '25\n‪‪−450.00 M‬‬\n‪0.00‬\n‪‪450.00 M‬‬\n‪‪900.00 M‬‬\n‪‪1.35 B‬‬\nDebt\nFree cash flow\nCash & equivalents\nEarnings\nNext:\nFeb 26, 2026\nQ4 '24\nQ1 '25\nQ2 '25\nQ3 '25\nQ4 '25\n‪0.00‬\n‪0.00‬\n‪0.00‬\n‪0.00‬\n‪0.00‬\nActual\n\nNo news here\nLooks like there's nothing to report right now\nReload\nIdeas\n\n\nNAKED CHART \/ PVA \/ BULL CS\nPREDICT PRICE DIRECTION ONLY\n\n\npva\n\nbull  cs\n\nchart pattern\nM\nby habb288\nDec 21, 2025\nPREDICT PRICE DIRECTION ONLY........TFW\nPredict\n\nprice will break zone \/R \/ box with volume\n\nwill test Resistance  \/ TP  TARGET\n\nduration monitoring - 2 to 4 weeks\n\nTFW - Top Volume\n\nmomentum stock\n\nRisk  -  penny  stock\nM\nby habb288\nNov 15, 2025\nPREDICT PRICE DIRECTION ONLY\nPredict\n\nprice will break zone \/R \/ box with volume\n\nwill test Resistance  \/ TP  TARGET\n\nduration monitoring - 2 to 4 weeks\n\nTFW - Top Volume\n\nmomentum stock\n\nRisk  -  penny  stock\nM\nby habb288\nNov 13, 2025\nPHARMANIAGA - Uptrend remains intact\nUptrend remains intact — price is respecting a higher-low trajectory drawn from late July towards October. Currently, price seems to be consolidating just above the trendline, which acts as a short-term dynamic support.\n\nThe consolidation phase looks healthy, suggesting accumulation rather than dist\nM\nby CyphuellAzm\nOct 8, 2025\nIDEA PREDICT PRICE DIRECTION ONLY\npredict \n\ntrend - uptrend\n\ncs -  bull cs\n\nduration monitoring - 2 to 4 weeks\nM\nby habb288\nSep 18, 2025\nPREDICT PRICE DIRECTION ONLY\nPredict\n\ntrend : uptrend\n\nduration monitoring : 2 - 4 weeks\nM\nby habb288\nSep 14, 2025\nPHARMA: LONG JOURNEY TO EXIT PN17\nThe company takes time to recover. Hope turns well\nM\nby RAR-BSJ\nJun 25, 2025\nPHARMA - Looking for bullish movement\nN wave with E, N & NT projection.\nThe stock has recently broken above a significant downtrend line, signaling a potential trend reversal from a prolonged downtrend.\nIt also recently moved above the Kumo, confirming bullish momentum.\nPullback after the wave B peak around 0.32, currently consolidating\nM\nLong\nby mg6112\nMay 18, 2025\nPharma Triple Top Pattern\nPharma, a company engange in research and developing medical drug and devices was a darling in pharmaceutical in Malaysia.\n    Recently, it had been hit hard with expired vaccine and the obsolete of PPE, needles etc (for Covid 19 use) impairment which was not utilised by the MOF.\n   The recovery of\nM\nShort\nby K_S_AbdHamid\nFeb 11, 2024\n2\nPharma, catching my attention\nAfter 2 weeks of rebounding from the bottom, it has come to the weekly trendline resistance at 0.425sen. Obviously it is not the right timing to enter as it will retrace anytime from the resistance line. \n Hence, the surge of price does not supported with volume. I will wait for the higher low form\nM\nby JeremyTee_ws\nDec 18, 2023\nSee all ideas\n \nTechnicals\n\n\nSummarizing what the indicators are\nsuggesting.\nNeutral\nSell\nBuy\nStrong sell\nStrong buy\nStrong sell\nSell\nNeutral\nBuy\nStrong buy\nNeutral\nSell\nBuy\nStrong sell\nStrong buy\nStrong sell\nSell\nNeutral\nBuy\nStrong buy\nNeutral\nSell\nBuy\nStrong sell\nStrong buy\nStrong sell\nSell\nNeutral\nBuy\nStrong buy\n\nAn aggregate view of professional's\nratings.\nNeutral\nSell\nBuy\nStrong sell\nStrong buy\nStrong sell\nSell\nNeutral\nBuy\nStrong buy\nNeutral\nSell\nBuy\nStrong sell\nStrong buy\nStrong sell\nSell\nNeutral\nBuy\nStrong buy\nNeutral\nSell\nBuy\nStrong sell\nStrong buy\nStrong sell\nSell\nNeutral\nBuy\nStrong buy\nSeasonals\n\n\nDisplays a symbol's price movements over previous years to identify recurring trends.\n\nThe current price of PHARMA is 0.290 MYR — it has decreased by −1.69% in the past 24 hours. Watch Pharmaniaga Bhd. stock price performance more closely on the\nchart\n.\nDepending on the exchange, the stock ticker may vary. For instance, on MYX exchange Pharmaniaga Bhd. stocks are traded under the ticker PHARMA.\nPHARMA stock has risen by 3.51% compared to the previous week, the month change is a 11.32% rise, over the last year Pharmaniaga Bhd. has showed a 47.82% increase.\nWe've gathered analysts' opinions on Pharmaniaga Bhd. future price: according to them, PHARMA price has a max estimate of 0.29 MYR and a min estimate of 0.15 MYR. Watch\nPHARMA chart\nand read a more detailed\nPharmaniaga Bhd. stock forecast\n: see what analysts think of Pharmaniaga Bhd. and suggest that you do with its stocks.\nPHARMA reached its all-time high on Apr 28, 2015 with the price of 0.895 MYR, and its all-time low was 0.110 MYR and was reached on Mar 23, 2020. View more price dynamics on\nPHARMA chart\n.\nSee other stocks reaching their\nhighest\nand\nlowest\nprices.\nPHARMA stock is 1.72% volatile and has beta coefficient of 2.72. Track Pharmaniaga Bhd. stock price on the\nchart\nand check out the list of the\nmost volatile stocks\n— is Pharmaniaga Bhd. there?\nToday Pharmaniaga Bhd. has the market capitalization of ‪1.93 B‬, it has increased by 1.79% over the last week.\nYes, you can track\nPharmaniaga Bhd. financials\nin yearly and quarterly reports right on TradingView.\nPharmaniaga Bhd. is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our\nEarnings Calendar\n.\nPHARMA net income for the last quarter is ‪7.28 M‬ MYR, while the quarter before that showed ‪3.96 M‬ MYR of net income which accounts for 83.74% change. Track more\nPharmaniaga Bhd. financial stats\nto get the full picture.\nAs of Jan 19, 2026, the company has ‪3.5 K‬ employees. See our rating of the\nlargest employees\n— is Pharmaniaga Bhd. on this list?\nEBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharmaniaga Bhd. EBITDA is ‪178.72 M‬ MYR, and current EBITDA margin is 8.16%. See more stats in\nPharmaniaga Bhd. financial statements\n.\nLike other stocks, PHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharmaniaga Bhd. stock right from TradingView charts — choose your\nbroker\nand connect to your account.\nInvesting in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharmaniaga Bhd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharmaniaga Bhd. stock shows the buy signal. See more of\nPharmaniaga Bhd. technicals\nfor a more comprehensive analysis.\nIf you're still not sure, try looking for inspiration in our\ncurated watchlists\n.","attrs_markdown":"Main content\n\nSearch\n\n- [Products](https:\/\/www.tradingview.com\/chart\/)\n- [Community](https:\/\/www.tradingview.com\/ideas\/)\n- [Markets](https:\/\/www.tradingview.com\/markets\/)\n- [Brokers](https:\/\/www.tradingview.com\/brokers\/)\n- [More](https:\/\/www.tradingview.com\/support\/)\n\nEN\n\n![]()\n\n[Get started](https:\/\/www.tradingview.com\/pricing\/?source=header_go_pro_button&feature=start_free_trial)\n\nPHARMAMarket closed\n\n0\\.290DMYR\n\n−0.005−1.69%\n\n[See on Supercharts](https:\/\/www.tradingview.com\/chart\/?symbol=MYX%3APHARMA)\n\n- [Markets](https:\/\/www.tradingview.com\/markets\/)\n- \/[Malaysia](https:\/\/www.tradingview.com\/markets\/malaysia\/)\n- \/[Stocks](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/market-movers-large-cap\/)\n- \/[Distribution Services](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/sectorandindustry-sector\/distribution-services\/)\n- \/[Medical Distributors](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/sectorandindustry-industry\/medical-distributors\/)\n- \/[PHARMA](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/)\n\n![Pharmaniaga Bhd.](https:\/\/s3-symbol-logo.tradingview.com\/pharmaniaga-bhd--big.svg)PP\n\n# Pharmaniaga Bhd.\nPHARMA![](https:\/\/s3-symbol-logo.tradingview.com\/source\/MYX.svg)Bursa Malaysia\n\nPHARMABursa Malaysia\n\nPHARMABursa Malaysia\n\nPHARMABursa Malaysia\n\nMarket closed\n\n0\\.290MYRD\n\n−0.005−1.69%\n\nAt close at 08:59 GMT\n\nMYR\n\nNo trades\n\n[Overview](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/)[Financials](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-overview\/)[News](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/news\/)[Ideas](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ideas\/)[Minds](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/minds\/)[Technicals](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/technicals\/)[Forecasts](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/forecast\/)[Seasonals](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/seasonals\/)\n\nMore\n\n[Chart ](https:\/\/www.tradingview.com\/chart\/?symbol=MYX%3APHARMA)\n\n[Full chart](https:\/\/www.tradingview.com\/chart\/?symbol=MYX%3APHARMA)\n\n1 day0\\.00%\n\n5 days3\\.51%\n\n1 month18\\.00%\n\n6 months90\\.32%\n\nYear to date3\\.51%\n\n1 year50\\.37%\n\n5 years−53.62%\n\n10 years−59.98%\n\nAll time46\\.45%\n\n[Upcoming earnings ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-earnings\/?earnings-period=FQ&revenues-period=FQ)\n\nNext report date\n\n≈\n\nFebruary 26\n\nReport period\n\nQ4 2025\n\nEPS estimate\n\n—\n\nRevenue estimate\n\n—\n\n[Key stats ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-overview\/)\n\nMarket capitalization\n\n‪1.93 B‬ MYR\n\n[Dividend yield (indicated)](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-dividends\/)\n\n—\n\n[Price to earnings Ratio (TTM)](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-statistics-and-ratios\/price-earnings\/)\n\n16\\.760\n\n[Basic EPS (TTM)](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-income-statement\/earnings-per-share-basic\/)\n\n0\\.020 MYR\n\n[Net income (FY)](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-income-statement\/net-income\/)\n\n‪131.82 M‬ MYR\n\n[Revenue (FY)](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-revenue\/)\n\n‪3.76 B‬ MYR\n\n[Shares float](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-statistics-and-ratios\/float-shares-outstanding\/)\n\n‪3.02 B‬\n\nBeta (1Y)\n\n2\\.74\n\n[Employees ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-statistics-and-ratios\/number-of-employees\/)\n\nEmployees (FY)\n\n‪3.5 K‬\n\nChange (1Y)\n\n\\+26 +0.75%\n\nRevenue \/ Employee (1Y)\n\n‪1.07 M‬ MYR\n\nNet income \/ Employee (1Y)\n\n‪37.64 K‬ MYR\n\n## About Pharmaniaga Bhd.\n\n\nSector\n\n[Distribution Services](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/sectorandindustry-sector\/distribution-services\/)\n\nIndustry\n\n[Medical Distributors](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/sectorandindustry-industry\/medical-distributors\/)\n\nCEO\n\nZulkifli bin Jafar\n\nWebsite\n\n[pharmaniaga.com](http:\/\/www.pharmaniaga.com\/)\n\nHeadquarters\n\nShah Alam\n\nFounded\n\n1994\n\nIdentifiers\n\n2\n\nISIN MYL7081OO002\n\nPharmaniaga Bhd. is as an investment holding company that engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. It operates through the following segments: Pharmaceutical Manufacturing, Pharmaceutical Trading, Marketing Distribution and E-Services, Medical Products and Services, and Others. The Pharmaceutical Manufacturing segment engages in manufacturing of pharmaceutical products. The Marketing Distribution and E-Services segment engages in purchasing, storage, distribution and marketing of pharmaceutical and medical products. The Medical Products and Services segment engages in supply and installation of medical and hospital equipment. The Others segment engages in investment holding. The company was founded in 1994 and is headquartered in Shah Alam, Malaysia.\n\nShow more\n\n[Financials ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-overview\/)\n\nPerformance\n\nAnnualAnnual\n\nQuarterlyQuarterly\n\nMore\n\nMore\n\n‪0.25%‬\n\n‪2.75%‬\n\n‪5.25%‬\n\n‪7.75%‬\n\n‪10.25%‬\n\nQ3 '24\n\nQ4 '24\n\nQ1 '25\n\nQ2 '25\n\nQ3 '25\n\n‪0.00‬\n\n‪‪300.00 M‬‬\n\n‪‪600.00 M‬‬\n\n‪‪900.00 M‬‬\n\n‪‪1.20 B‬‬\n\nRevenue\n\nNet income\n\nNet margin %\n\nRevenue to profit\n\nconversion\n\nAnnualAnnual\n\nQuarterlyQuarterly\n\nMore\n\nMore\n\nRevenue\n\nCOGS\n\nGross profit\n\nOp expenses\n\nOp income\n\nNon-Op income\/ expenses\n\nTaxes & Other\n\nNet income\n\n‪0.00‬\n\n‪‪260.00 M‬‬\n\n‪‪520.00 M‬‬\n\n‪‪780.00 M‬‬\n\n‪‪1.04 B‬‬\n\nRevenue\n\nCOGS\n\nGross profit\n\nExpenses & adjustments\n\nNet income\n\n‪0.00‬\n\n‪‪260.00 M‬‬\n\n‪‪520.00 M‬‬\n\n‪‪780.00 M‬‬\n\n‪‪1.04 B‬‬\n\nDebt level and\n\ncoverage\n\nAnnualAnnual\n\nQuarterlyQuarterly\n\nMore\n\nMore\n\nQ3 '24\n\nQ4 '24\n\nQ1 '25\n\nQ2 '25\n\nQ3 '25\n\n‪‪−450.00 M‬‬\n\n‪0.00‬\n\n‪‪450.00 M‬‬\n\n‪‪900.00 M‬‬\n\n‪‪1.35 B‬‬\n\nDebt\n\nFree cash flow\n\nCash & equivalents\n\nEarnings\n\nNext:Feb 26, 2026\n\nAnnualAnnual\n\nQuarterlyQuarterly\n\nMore\n\nMore\n\nQ4 '24\n\nQ1 '25\n\nQ2 '25\n\nQ3 '25\n\nQ4 '25\n\n‪0.00‬\n\n‪0.00‬\n\n‪0.00‬\n\n‪0.00‬\n\n‪0.00‬\n\nActual\n\n[News ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/news\/)\n\nNo news here\n\nLooks like there's nothing to report right now\n\n[Reload](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/)\n\n[Ideas ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ideas\/)\n\n[NAKED CHART \/ PVA \/ BULL CS](https:\/\/www.tradingview.com\/chart\/PHARMA\/aKl44cVx-NAKED-CHART-PVA-BULL-CS\/) [PREDICT PRICE DIRECTION ONLY pva bull cs chart pattern](https:\/\/www.tradingview.com\/chart\/PHARMA\/aKl44cVx-NAKED-CHART-PVA-BULL-CS\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\n[![](https:\/\/s3.tradingview.com\/a\/aKl44cVx_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/aKl44cVx-NAKED-CHART-PVA-BULL-CS\/)\n\n[by habb288](https:\/\/www.tradingview.com\/u\/habb288\/)\n\nDec 21, 2025\n\n0\n\n[PREDICT PRICE DIRECTION ONLY........TFW](https:\/\/www.tradingview.com\/chart\/PHARMA\/Myvaovc5-PREDICT-PRICE-DIRECTION-ONLY-TFW\/)[Predict price will break zone \/R \/ box with volume will test Resistance \/ TP TARGET duration monitoring - 2 to 4 weeks TFW - Top Volume momentum stock Risk - penny stock](https:\/\/www.tradingview.com\/chart\/PHARMA\/Myvaovc5-PREDICT-PRICE-DIRECTION-ONLY-TFW\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\n[![](https:\/\/s3.tradingview.com\/m\/Myvaovc5_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/Myvaovc5-PREDICT-PRICE-DIRECTION-ONLY-TFW\/)\n\n[by habb288](https:\/\/www.tradingview.com\/u\/habb288\/)\n\nNov 15, 2025\n\n0\n\n[PREDICT PRICE DIRECTION ONLY](https:\/\/www.tradingview.com\/chart\/PHARMA\/RkeRzmhj-PREDICT-PRICE-DIRECTION-ONLY\/)[Predict price will break zone \/R \/ box with volume will test Resistance \/ TP TARGET duration monitoring - 2 to 4 weeks TFW - Top Volume momentum stock Risk - penny stock](https:\/\/www.tradingview.com\/chart\/PHARMA\/RkeRzmhj-PREDICT-PRICE-DIRECTION-ONLY\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\n[![](https:\/\/s3.tradingview.com\/r\/RkeRzmhj_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/RkeRzmhj-PREDICT-PRICE-DIRECTION-ONLY\/)\n\n[by habb288](https:\/\/www.tradingview.com\/u\/habb288\/)\n\nNov 13, 2025\n\n0\n\n[PHARMANIAGA - Uptrend remains intact](https:\/\/www.tradingview.com\/chart\/PHARMA\/cqLjnZ0Z-PHARMANIAGA-Uptrend-remains-intact\/)[Uptrend remains intact — price is respecting a higher-low trajectory drawn from late July towards October. Currently, price seems to be consolidating just above the trendline, which acts as a short-term dynamic support. The consolidation phase looks healthy, suggesting accumulation rather than dist](https:\/\/www.tradingview.com\/chart\/PHARMA\/cqLjnZ0Z-PHARMANIAGA-Uptrend-remains-intact\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\n[![](https:\/\/s3.tradingview.com\/c\/cqLjnZ0Z_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/cqLjnZ0Z-PHARMANIAGA-Uptrend-remains-intact\/)\n\n[by CyphuellAzm](https:\/\/www.tradingview.com\/u\/CyphuellAzm\/)\n\nOct 8, 2025\n\n1\n\n[IDEA PREDICT PRICE DIRECTION ONLY](https:\/\/www.tradingview.com\/chart\/PHARMA\/CSrEYrYp-IDEA-PREDICT-PRICE-DIRECTION-ONLY\/)[predict trend - uptrend cs - bull cs duration monitoring - 2 to 4 weeks](https:\/\/www.tradingview.com\/chart\/PHARMA\/CSrEYrYp-IDEA-PREDICT-PRICE-DIRECTION-ONLY\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\n[![](https:\/\/s3.tradingview.com\/c\/CSrEYrYp_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/CSrEYrYp-IDEA-PREDICT-PRICE-DIRECTION-ONLY\/)\n\n[by habb288](https:\/\/www.tradingview.com\/u\/habb288\/)\n\nSep 18, 2025\n\n4\n\n[PREDICT PRICE DIRECTION ONLY](https:\/\/www.tradingview.com\/chart\/PHARMA\/WXWEqdUI-PREDICT-PRICE-DIRECTION-ONLY\/)[Predict trend : uptrend duration monitoring : 2 - 4 weeks](https:\/\/www.tradingview.com\/chart\/PHARMA\/WXWEqdUI-PREDICT-PRICE-DIRECTION-ONLY\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\n[![](https:\/\/s3.tradingview.com\/w\/WXWEqdUI_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/WXWEqdUI-PREDICT-PRICE-DIRECTION-ONLY\/)\n\n[by habb288](https:\/\/www.tradingview.com\/u\/habb288\/)\n\nSep 14, 2025\n\n0\n\n[PHARMA: LONG JOURNEY TO EXIT PN17](https:\/\/www.tradingview.com\/chart\/PHARMA\/xS5vQ3lI-PHARMA-LONG-JOURNEY-TO-EXIT-PN17\/)[The company takes time to recover. Hope turns well](https:\/\/www.tradingview.com\/chart\/PHARMA\/xS5vQ3lI-PHARMA-LONG-JOURNEY-TO-EXIT-PN17\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\n[![](https:\/\/s3.tradingview.com\/x\/xS5vQ3lI_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/xS5vQ3lI-PHARMA-LONG-JOURNEY-TO-EXIT-PN17\/)\n\n[by RAR-BSJ](https:\/\/www.tradingview.com\/u\/RAR-BSJ\/)\n\nJun 25, 2025\n\n0\n\n[PHARMA - Looking for bullish movement](https:\/\/www.tradingview.com\/chart\/PHARMA\/fm7Wy8TE-PHARMA-Looking-for-bullish-movement\/)[N wave with E, N & NT projection. The stock has recently broken above a significant downtrend line, signaling a potential trend reversal from a prolonged downtrend. It also recently moved above the Kumo, confirming bullish momentum. Pullback after the wave B peak around 0.32, currently consolidating](https:\/\/www.tradingview.com\/chart\/PHARMA\/fm7Wy8TE-PHARMA-Looking-for-bullish-movement\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\nLong\n\n[![](https:\/\/s3.tradingview.com\/f\/fm7Wy8TE_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/fm7Wy8TE-PHARMA-Looking-for-bullish-movement\/)\n\n[by mg6112](https:\/\/www.tradingview.com\/u\/mg6112\/)\n\nMay 18, 2025\n\n0\n\n[Pharma Triple Top Pattern](https:\/\/www.tradingview.com\/chart\/PHARMA\/Mi9UtlC1-Pharma-Triple-Top-Pattern\/)[Pharma, a company engange in research and developing medical drug and devices was a darling in pharmaceutical in Malaysia. Recently, it had been hit hard with expired vaccine and the obsolete of PPE, needles etc (for Covid 19 use) impairment which was not utilised by the MOF. The recovery of](https:\/\/www.tradingview.com\/chart\/PHARMA\/Mi9UtlC1-Pharma-Triple-Top-Pattern\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\nShort\n\n[![](https:\/\/s3.tradingview.com\/m\/Mi9UtlC1_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/Mi9UtlC1-Pharma-Triple-Top-Pattern\/)\n\n[by K\\_S\\_AbdHamid](https:\/\/www.tradingview.com\/u\/K_S_AbdHamid\/)\n\nFeb 11, 2024\n\n[22](https:\/\/www.tradingview.com\/chart\/PHARMA\/Mi9UtlC1-Pharma-Triple-Top-Pattern\/#chart-view-comment-form \"Comment\")\n\n0\n\n[Pharma, catching my attention](https:\/\/www.tradingview.com\/chart\/PHARMA\/aURR4naL-Pharma-catching-my-attention\/)[After 2 weeks of rebounding from the bottom, it has come to the weekly trendline resistance at 0.425sen. Obviously it is not the right timing to enter as it will retrace anytime from the resistance line. Hence, the surge of price does not supported with volume. I will wait for the higher low form](https:\/\/www.tradingview.com\/chart\/PHARMA\/aURR4naL-Pharma-catching-my-attention\/)\n\n[M](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ \"MYX:PHARMA\")\n\n[![](https:\/\/s3.tradingview.com\/a\/aURR4naL_mid.png)](https:\/\/www.tradingview.com\/chart\/PHARMA\/aURR4naL-Pharma-catching-my-attention\/)\n\n[by JeremyTee\\_ws](https:\/\/www.tradingview.com\/u\/JeremyTee_ws\/)\n\nDec 18, 2023\n\n1\n\n[See all ideas](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/ideas\/)\n\n[Technicals ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/technicals\/)\n\nSummarizing what the indicators are\n\nsuggesting.\n\nNeutral\n\nSellBuy\n\nStrong sellStrong buy\n\nStrong sellSellNeutralBuyStrong buy\n\nNeutral\n\nSellBuy\n\nStrong sellStrong buy\n\nStrong sellSellNeutralBuyStrong buy\n\nNeutral\n\nSellBuy\n\nStrong sellStrong buy\n\nStrong sellSellNeutralBuyStrong buy\n\n[Analyst rating ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/forecast\/)\n\nAn aggregate view of professional's\n\nratings.\n\nNeutral\n\nSellBuy\n\nStrong sellStrong buy\n\nStrong sellSellNeutralBuyStrong buy\n\nNeutral\n\nSellBuy\n\nStrong sellStrong buy\n\nStrong sellSellNeutralBuyStrong buy\n\nNeutral\n\nSellBuy\n\nStrong sellStrong buy\n\nStrong sellSellNeutralBuyStrong buy\n\n[Seasonals ](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/seasonals\/)\n\nDisplays a symbol's price movements over previous years to identify recurring trends.\n\n## Frequently Asked Questions\n\n\nWhat is Pharmaniaga Bhd. stock price today?\n\nThe current price of PHARMA is 0.290 MYR — it has decreased by −1.69% in the past 24 hours. Watch Pharmaniaga Bhd. stock price performance more closely on the [chart](https:\/\/www.tradingview.com\/chart\/?symbol=MYX:PHARMA).\n\nWhat is Pharmaniaga Bhd. stock ticker?\n\nDepending on the exchange, the stock ticker may vary. For instance, on MYX exchange Pharmaniaga Bhd. stocks are traded under the ticker PHARMA.\n\nIs Pharmaniaga Bhd. stock price growing?\n\nPHARMA stock has risen by 3.51% compared to the previous week, the month change is a 11.32% rise, over the last year Pharmaniaga Bhd. has showed a 47.82% increase.\n\nWhat is PHARMA stock forecast?\n\nWe've gathered analysts' opinions on Pharmaniaga Bhd. future price: according to them, PHARMA price has a max estimate of 0.29 MYR and a min estimate of 0.15 MYR. Watch [PHARMA chart](https:\/\/www.tradingview.com\/chart\/?symbol=MYX:PHARMA) and read a more detailed [Pharmaniaga Bhd. stock forecast](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/forecast\/): see what analysts think of Pharmaniaga Bhd. and suggest that you do with its stocks.\n\nWhat are Pharmaniaga Bhd. stock highest and lowest prices ever?\n\nPHARMA reached its all-time high on Apr 28, 2015 with the price of 0.895 MYR, and its all-time low was 0.110 MYR and was reached on Mar 23, 2020. View more price dynamics on [PHARMA chart](https:\/\/www.tradingview.com\/chart\/?symbol=MYX:PHARMA).   \nSee other stocks reaching their [highest](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/market-movers-ath\/) and [lowest](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/market-movers-atl\/) prices.\n\nHow volatile is PHARMA stock?\n\nPHARMA stock is 1.72% volatile and has beta coefficient of 2.72. Track Pharmaniaga Bhd. stock price on the [chart](https:\/\/www.tradingview.com\/chart\/?symbol=MYX:PHARMA) and check out the list of the [most volatile stocks](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/market-movers-most-volatile\/) — is Pharmaniaga Bhd. there?\n\nWhat is Pharmaniaga Bhd. market cap?\n\nToday Pharmaniaga Bhd. has the market capitalization of ‪1.93 B‬, it has increased by 1.79% over the last week.\n\nDoes Pharmaniaga Bhd. release reports?\n\nYes, you can track [Pharmaniaga Bhd. financials](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-income-statement\/) in yearly and quarterly reports right on TradingView.\n\nWhen is the next Pharmaniaga Bhd. earnings date?\n\nPharmaniaga Bhd. is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our [Earnings Calendar](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/earnings\/).\n\nWhat is PHARMA net income for the last quarter?\n\nPHARMA net income for the last quarter is ‪7.28 M‬ MYR, while the quarter before that showed ‪3.96 M‬ MYR of net income which accounts for 83.74% change. Track more [Pharmaniaga Bhd. financial stats](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-income-statement\/) to get the full picture.\n\nHow many employees does Pharmaniaga Bhd. have?\n\nAs of Jan 19, 2026, the company has ‪3.5 K‬ employees. See our rating of the [largest employees](https:\/\/www.tradingview.com\/markets\/stocks-malaysia\/market-movers-largest-employers\/) — is Pharmaniaga Bhd. on this list?\n\nWhat is Pharmaniaga Bhd. EBITDA?\n\nEBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharmaniaga Bhd. EBITDA is ‪178.72 M‬ MYR, and current EBITDA margin is 8.16%. See more stats in [Pharmaniaga Bhd. financial statements](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/financials-income-statement\/).\n\nHow to buy Pharmaniaga Bhd. stocks?\n\nLike other stocks, PHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharmaniaga Bhd. stock right from TradingView charts — choose your [broker](https:\/\/www.tradingview.com\/brokers\/) and connect to your account.\n\nShould I invest in Pharmaniaga Bhd. stock?\n\nInvesting in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharmaniaga Bhd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharmaniaga Bhd. stock shows the buy signal. See more of [Pharmaniaga Bhd. technicals](https:\/\/www.tradingview.com\/symbols\/MYX-PHARMA\/technicals\/) for a more comprehensive analysis.  \n If you're still not sure, try looking for inspiration in our [curated watchlists](https:\/\/www.tradingview.com\/sparks\/).\n\n***\nEnglishEnglish\n\nSelect market data provided by [ICE Data Services](https:\/\/www.theice.com\/market-data). Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC fillings and other documents provided by [Quartr](https:\/\/www.quartr.com\/).© 2026 TradingView, Inc.\n\nMore than a product\n\n- [Supercharts](https:\/\/www.tradingview.com\/chart\/)\n\nScreeners\n\n- [Stocks](https:\/\/www.tradingview.com\/screener\/)\n- [ETFs](https:\/\/www.tradingview.com\/etf-screener\/)\n- [Bonds](https:\/\/www.tradingview.com\/bond-screener\/)\n- [Crypto coins](https:\/\/www.tradingview.com\/crypto-coins-screener\/)\n- [CEX pairs](https:\/\/www.tradingview.com\/cex-screener\/)\n- [DEX pairs](https:\/\/www.tradingview.com\/dex-screener\/)\n- [Pine](https:\/\/www.tradingview.com\/pine-screener\/)\n\nHeatmaps\n\n- [Stocks](https:\/\/www.tradingview.com\/heatmap\/stock\/)\n- [ETFs](https:\/\/www.tradingview.com\/heatmap\/etf\/)\n- [Crypto](https:\/\/www.tradingview.com\/heatmap\/crypto\/)\n\nCalendars\n\n- [Economic](https:\/\/www.tradingview.com\/economic-calendar\/)\n- [Earnings](https:\/\/www.tradingview.com\/earnings-calendar\/)\n- [Dividends](https:\/\/www.tradingview.com\/dividend-calendar\/)\n\nMore products\n\n- [Yield Curves](https:\/\/www.tradingview.com\/yield-curves\/)\n- [Options](https:\/\/www.tradingview.com\/options\/)\n- [News Flow](https:\/\/www.tradingview.com\/news-flow\/)\n- [Pine Script®](https:\/\/www.tradingview.com\/pine-script-docs\/)\n\nApps\n\n- [Mobile](https:\/\/www.tradingview.com\/mobile\/)\n- [Desktop](https:\/\/www.tradingview.com\/desktop\/)\n\nCommunity\n\n- [Social network](https:\/\/www.tradingview.com\/social-network\/)\n- [Wall of Love](https:\/\/www.tradingview.com\/wall-of-love\/)\n- [Refer a friend](https:\/\/www.tradingview.com\/share-your-love\/?source=footer&feature=refer_friend)\n- [House Rules](https:\/\/www.tradingview.com\/house-rules\/)\n- [Moderators](https:\/\/www.tradingview.com\/moderators\/)\n\nIdeas\n\n- [Trading](https:\/\/www.tradingview.com\/ideas\/)\n- [Education](https:\/\/www.tradingview.com\/ideas\/?type=education)\n- [Editors' picks](https:\/\/www.tradingview.com\/ideas\/editors-picks\/)\n\nPine Script\n\n- [Indicators & strategies](https:\/\/www.tradingview.com\/scripts\/)\n- [Wizards](https:\/\/www.tradingview.com\/pine-wizards\/)\n- [Freelancers](https:\/\/www.tradingview.com\/pine-script-freelancers\/)\n\nTools & subscriptions\n\n- [Features](https:\/\/www.tradingview.com\/features\/)\n- [Pricing](https:\/\/www.tradingview.com\/pricing\/?source=footer&feature=pricing)\n- [Market data](https:\/\/www.tradingview.com\/data-coverage\/)\n- [Gift plans](https:\/\/www.tradingview.com\/gifts\/)\n\nTrading\n\n- [Overview](https:\/\/www.tradingview.com\/trading\/)\n- [Brokers](https:\/\/www.tradingview.com\/brokers\/)\n\nSpecial offers\n\n- [CME Group futures](https:\/\/www.tradingview.com\/cme\/)\n- [Eurex futures](https:\/\/www.tradingview.com\/eurex\/)\n- [US stocks bundle](https:\/\/www.tradingview.com\/us-markets-bundle\/)\n\nAbout company\n\n- [Who we are](https:\/\/www.tradingview.com\/about\/)\n- [Space mission](https:\/\/www.tradingview.com\/space-mission\/)\n- [Blog](https:\/\/www.tradingview.com\/blog\/en\/)\n- [Careers](https:\/\/www.tradingview.com\/careers\/)\n- [Media kit](https:\/\/www.tradingview.com\/media-kit\/)\n\nMerch\n\n- [TradingView store](https:\/\/tradingviewstore.com\/)\n- [Tarot cards for traders](https:\/\/www.tradingview.com\/tarot-reading\/)\n- [The C63 TradeTime](https:\/\/www.tradingview.com\/tradetime\/)\n\nPolicies & security\n\n- [Terms of Use](https:\/\/www.tradingview.com\/policies\/)\n- [Disclaimer](https:\/\/www.tradingview.com\/disclaimer\/)\n- [Privacy Policy](https:\/\/www.tradingview.com\/privacy-policy\/)\n- [Cookies Policy](https:\/\/www.tradingview.com\/cookies-policy\/)\n- [Accessibility Statement](https:\/\/www.tradingview.com\/accessibility\/)\n- [Security tips](https:\/\/www.tradingview.com\/security\/)\n- [Bug Bounty program](https:\/\/www.tradingview.com\/bounty\/)\n- [Status page](https:\/\/status.tradingview.com\/)\n\nBusiness solutions\n\n- [Widgets](https:\/\/www.tradingview.com\/widget\/)\n- [Charting libraries](https:\/\/www.tradingview.com\/free-charting-libraries\/)\n- [Lightweight Charts™](https:\/\/www.tradingview.com\/lightweight-charts\/)\n- [Advanced Charts](https:\/\/www.tradingview.com\/advanced-charts\/)\n- [Trading Platform](https:\/\/www.tradingview.com\/trading-platform\/)\n\nGrowth opportunities\n\n- [Advertising](https:\/\/www.tradingview.com\/advertising-info\/)\n- [Brokerage integration](https:\/\/www.tradingview.com\/brokerage-integration\/)\n- [Partner program](https:\/\/www.tradingview.com\/partner-program\/)\n- [Education program](https:\/\/www.tradingview.com\/students\/)\n\nCommunity\n\n- [Social network](https:\/\/www.tradingview.com\/social-network\/)\n- [Wall of Love](https:\/\/www.tradingview.com\/wall-of-love\/)\n- [Refer a friend](https:\/\/www.tradingview.com\/share-your-love\/?source=footer&feature=refer_friend)\n- [House Rules](https:\/\/www.tradingview.com\/house-rules\/)\n- [Moderators](https:\/\/www.tradingview.com\/moderators\/)\n\nIdeas\n\n- [Trading](https:\/\/www.tradingview.com\/ideas\/)\n- [Education](https:\/\/www.tradingview.com\/ideas\/?type=education)\n- [Editors' picks](https:\/\/www.tradingview.com\/ideas\/editors-picks\/)\n\nPine Script\n\n- [Indicators & strategies](https:\/\/www.tradingview.com\/scripts\/)\n- [Wizards](https:\/\/www.tradingview.com\/pine-wizards\/)\n- [Freelancers](https:\/\/www.tradingview.com\/pine-script-freelancers\/)\n\nBusiness solutions\n\n- [Widgets](https:\/\/www.tradingview.com\/widget\/)\n- [Charting libraries](https:\/\/www.tradingview.com\/free-charting-libraries\/)\n- [Lightweight Charts™](https:\/\/www.tradingview.com\/lightweight-charts\/)\n- [Advanced Charts](https:\/\/www.tradingview.com\/advanced-charts\/)\n- [Trading Platform](https:\/\/www.tradingview.com\/trading-platform\/)\n\nGrowth opportunities\n\n- [Advertising](https:\/\/www.tradingview.com\/advertising-info\/)\n- [Brokerage integration](https:\/\/www.tradingview.com\/brokerage-integration\/)\n- [Partner program](https:\/\/www.tradingview.com\/partner-program\/)\n- [Education program](https:\/\/www.tradingview.com\/students\/)\n\n![Look First](https:\/\/static.tradingview.com\/static\/bundles\/look-first-dark.8cb7462c584f600e8f31.svg)![Look First](https:\/\/static.tradingview.com\/static\/bundles\/look-first-light.74b5bba06f657157cdb4.svg)\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more\n\nShow more","attrs_readable_markdown":null,"meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

2 months ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	2.6 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.tradingview.com/symbols/MYX-PHARMA/
Last Crawled	2026-01-19 09:43:44 (2 months ago)
First Indexed	2019-11-15 17:16:05 (6 years ago)
HTTP Status Code	200
Meta Title	PHARMA Stock Price and Chart — MYX:PHARMA — TradingView
Meta Description	View live Pharmaniaga Bhd. chart to track its stock's price action. Find market predictions, PHARMA financials and market news.
Meta Canonical	null
Boilerpipe Text	Full chart Upcoming earnings Next report date ≈ February 26 Report period Q4 2025 EPS estimate — Revenue estimate — Key stats Market capitalization ‪1.93 B‬  MYR Dividend yield (indicated) — Price to earnings Ratio (TTM) 16.760 Basic EPS (TTM) 0.020  MYR Net income (FY) ‪131.82 M‬  MYR Revenue (FY) ‪3.76 B‬  MYR Shares float ‪3.02 B‬ Beta (1Y) 2.74 Employees Employees (FY) ‪3.5 K‬ Change (1Y) +26 +0.75% Revenue / Employee (1Y) ‪1.07 M‬  MYR Net income / Employee (1Y) ‪37.64 K‬  MYR About Pharmaniaga Bhd. Sector Distribution Services Industry Medical Distributors CEO Zulkifli bin Jafar Website pharmaniaga.com Headquarters Shah Alam Founded 1994 Identifiers 2 ISIN MYL7081OO002 Pharmaniaga Bhd. is as an investment holding company that engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. It operates through the following segments: Pharmaceutical Manufacturing, Pharmaceutical Trading, Marketing Distribution and E-Services, Medical Products and Services, and Others. The Pharmaceutical Manufacturing segment engages in manufacturing of pharmaceutical products. The Marketing Distribution and E-Services segment engages in purchasing, storage, distribution and marketing of pharmaceutical and medical products. The Medical Products and Services segment engages in supply and installation of medical and hospital equipment. The Others segment engages in investment holding. The company was founded in 1994 and is headquartered in Shah Alam, Malaysia. Financials Performance ‪0.25%‬ ‪2.75%‬ ‪5.25%‬ ‪7.75%‬ ‪10.25%‬ Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 ‪0.00‬ ‪‪300.00 M‬‬ ‪‪600.00 M‬‬ ‪‪900.00 M‬‬ ‪‪1.20 B‬‬ Revenue Net income Net margin % Revenue to profit conversion Revenue COGS Gross profit Op expenses Op income Non-Op income/ expenses Taxes & Other Net income ‪0.00‬ ‪‪260.00 M‬‬ ‪‪520.00 M‬‬ ‪‪780.00 M‬‬ ‪‪1.04 B‬‬ Revenue COGS Gross profit Expenses & adjustments Net income ‪0.00‬ ‪‪260.00 M‬‬ ‪‪520.00 M‬‬ ‪‪780.00 M‬‬ ‪‪1.04 B‬‬ Debt level and coverage Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 ‪‪−450.00 M‬‬ ‪0.00‬ ‪‪450.00 M‬‬ ‪‪900.00 M‬‬ ‪‪1.35 B‬‬ Debt Free cash flow Cash & equivalents Earnings Next: Feb 26, 2026 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 ‪0.00‬ ‪0.00‬ ‪0.00‬ ‪0.00‬ ‪0.00‬ Actual No news here Looks like there's nothing to report right now Reload Ideas NAKED CHART / PVA / BULL CS PREDICT PRICE DIRECTION ONLY pva bull cs chart pattern M by habb288 Dec 21, 2025 PREDICT PRICE DIRECTION ONLY........TFW Predict price will break zone /R / box with volume will test Resistance / TP TARGET duration monitoring - 2 to 4 weeks TFW - Top Volume momentum stock Risk - penny stock M by habb288 Nov 15, 2025 PREDICT PRICE DIRECTION ONLY Predict price will break zone /R / box with volume will test Resistance / TP TARGET duration monitoring - 2 to 4 weeks TFW - Top Volume momentum stock Risk - penny stock M by habb288 Nov 13, 2025 PHARMANIAGA - Uptrend remains intact Uptrend remains intact — price is respecting a higher-low trajectory drawn from late July towards October. Currently, price seems to be consolidating just above the trendline, which acts as a short-term dynamic support. The consolidation phase looks healthy, suggesting accumulation rather than dist M by CyphuellAzm Oct 8, 2025 IDEA PREDICT PRICE DIRECTION ONLY predict trend - uptrend cs - bull cs duration monitoring - 2 to 4 weeks M by habb288 Sep 18, 2025 PREDICT PRICE DIRECTION ONLY Predict trend : uptrend duration monitoring : 2 - 4 weeks M by habb288 Sep 14, 2025 PHARMA: LONG JOURNEY TO EXIT PN17 The company takes time to recover. Hope turns well M by RAR-BSJ Jun 25, 2025 PHARMA - Looking for bullish movement N wave with E, N & NT projection. The stock has recently broken above a significant downtrend line, signaling a potential trend reversal from a prolonged downtrend. It also recently moved above the Kumo, confirming bullish momentum. Pullback after the wave B peak around 0.32, currently consolidating M Long by mg6112 May 18, 2025 Pharma Triple Top Pattern Pharma, a company engange in research and developing medical drug and devices was a darling in pharmaceutical in Malaysia. Recently, it had been hit hard with expired vaccine and the obsolete of PPE, needles etc (for Covid 19 use) impairment which was not utilised by the MOF. The recovery of M Short by K_S_AbdHamid Feb 11, 2024 2 Pharma, catching my attention After 2 weeks of rebounding from the bottom, it has come to the weekly trendline resistance at 0.425sen. Obviously it is not the right timing to enter as it will retrace anytime from the resistance line. Hence, the surge of price does not supported with volume. I will wait for the higher low form M by JeremyTee_ws Dec 18, 2023 See all ideas Technicals Summarizing what the indicators are suggesting. Neutral Sell Buy Strong sell Strong buy Strong sell Sell Neutral Buy Strong buy Neutral Sell Buy Strong sell Strong buy Strong sell Sell Neutral Buy Strong buy Neutral Sell Buy Strong sell Strong buy Strong sell Sell Neutral Buy Strong buy An aggregate view of professional's ratings. Neutral Sell Buy Strong sell Strong buy Strong sell Sell Neutral Buy Strong buy Neutral Sell Buy Strong sell Strong buy Strong sell Sell Neutral Buy Strong buy Neutral Sell Buy Strong sell Strong buy Strong sell Sell Neutral Buy Strong buy Seasonals Displays a symbol's price movements over previous years to identify recurring trends. The current price of PHARMA is 0.290 MYR — it has decreased by −1.69% in the past 24 hours. Watch Pharmaniaga Bhd. stock price performance more closely on the chart . Depending on the exchange, the stock ticker may vary. For instance, on MYX exchange Pharmaniaga Bhd. stocks are traded under the ticker PHARMA. PHARMA stock has risen by 3.51% compared to the previous week, the month change is a 11.32% rise, over the last year Pharmaniaga Bhd. has showed a 47.82% increase. We've gathered analysts' opinions on Pharmaniaga Bhd. future price: according to them, PHARMA price has a max estimate of 0.29 MYR and a min estimate of 0.15 MYR. Watch PHARMA chart and read a more detailed Pharmaniaga Bhd. stock forecast : see what analysts think of Pharmaniaga Bhd. and suggest that you do with its stocks. PHARMA reached its all-time high on Apr 28, 2015 with the price of 0.895 MYR, and its all-time low was 0.110 MYR and was reached on Mar 23, 2020. View more price dynamics on PHARMA chart . See other stocks reaching their highest and lowest prices. PHARMA stock is 1.72% volatile and has beta coefficient of 2.72. Track Pharmaniaga Bhd. stock price on the chart and check out the list of the most volatile stocks — is Pharmaniaga Bhd. there? Today Pharmaniaga Bhd. has the market capitalization of ‪1.93 B‬, it has increased by 1.79% over the last week. Yes, you can track Pharmaniaga Bhd. financials in yearly and quarterly reports right on TradingView. Pharmaniaga Bhd. is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar . PHARMA net income for the last quarter is ‪7.28 M‬ MYR, while the quarter before that showed ‪3.96 M‬ MYR of net income which accounts for 83.74% change. Track more Pharmaniaga Bhd. financial stats to get the full picture. As of Jan 19, 2026, the company has ‪3.5 K‬ employees. See our rating of the largest employees — is Pharmaniaga Bhd. on this list? EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharmaniaga Bhd. EBITDA is ‪178.72 M‬ MYR, and current EBITDA margin is 8.16%. See more stats in Pharmaniaga Bhd. financial statements . Like other stocks, PHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharmaniaga Bhd. stock right from TradingView charts — choose your broker and connect to your account. Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharmaniaga Bhd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharmaniaga Bhd. stock shows the buy signal. See more of Pharmaniaga Bhd. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists .
Markdown	Main content Search - [Products](https://www.tradingview.com/chart/) - [Community](https://www.tradingview.com/ideas/) - [Markets](https://www.tradingview.com/markets/) - [Brokers](https://www.tradingview.com/brokers/) - [More](https://www.tradingview.com/support/) EN ![]() [Get started](https://www.tradingview.com/pricing/?source=header_go_pro_button&feature=start_free_trial) PHARMAMarket closed 0\.290DMYR −0.005−1.69% [See on Supercharts](https://www.tradingview.com/chart/?symbol=MYX%3APHARMA) - [Markets](https://www.tradingview.com/markets/) - /[Malaysia](https://www.tradingview.com/markets/malaysia/) - /[Stocks](https://www.tradingview.com/markets/stocks-malaysia/market-movers-large-cap/) - /[Distribution Services](https://www.tradingview.com/markets/stocks-malaysia/sectorandindustry-sector/distribution-services/) - /[Medical Distributors](https://www.tradingview.com/markets/stocks-malaysia/sectorandindustry-industry/medical-distributors/) - /[PHARMA](https://www.tradingview.com/symbols/MYX-PHARMA/) ![Pharmaniaga Bhd.](https://s3-symbol-logo.tradingview.com/pharmaniaga-bhd--big.svg)PP # Pharmaniaga Bhd. PHARMA![](https://s3-symbol-logo.tradingview.com/source/MYX.svg)Bursa Malaysia PHARMABursa Malaysia PHARMABursa Malaysia PHARMABursa Malaysia Market closed 0\.290MYRD −0.005−1.69% At close at 08:59 GMT MYR No trades [Overview](https://www.tradingview.com/symbols/MYX-PHARMA/)[Financials](https://www.tradingview.com/symbols/MYX-PHARMA/financials-overview/)[News](https://www.tradingview.com/symbols/MYX-PHARMA/news/)[Ideas](https://www.tradingview.com/symbols/MYX-PHARMA/ideas/)[Minds](https://www.tradingview.com/symbols/MYX-PHARMA/minds/)[Technicals](https://www.tradingview.com/symbols/MYX-PHARMA/technicals/)[Forecasts](https://www.tradingview.com/symbols/MYX-PHARMA/forecast/)[Seasonals](https://www.tradingview.com/symbols/MYX-PHARMA/seasonals/) More [Chart ](https://www.tradingview.com/chart/?symbol=MYX%3APHARMA) [Full chart](https://www.tradingview.com/chart/?symbol=MYX%3APHARMA) 1 day0\.00% 5 days3\.51% 1 month18\.00% 6 months90\.32% Year to date3\.51% 1 year50\.37% 5 years−53.62% 10 years−59.98% All time46\.45% [Upcoming earnings ](https://www.tradingview.com/symbols/MYX-PHARMA/financials-earnings/?earnings-period=FQ&revenues-period=FQ) Next report date ≈ February 26 Report period Q4 2025 EPS estimate — Revenue estimate — [Key stats ](https://www.tradingview.com/symbols/MYX-PHARMA/financials-overview/) Market capitalization ‪1.93 B‬ MYR [Dividend yield (indicated)](https://www.tradingview.com/symbols/MYX-PHARMA/financials-dividends/) — [Price to earnings Ratio (TTM)](https://www.tradingview.com/symbols/MYX-PHARMA/financials-statistics-and-ratios/price-earnings/) 16\.760 [Basic EPS (TTM)](https://www.tradingview.com/symbols/MYX-PHARMA/financials-income-statement/earnings-per-share-basic/) 0\.020 MYR [Net income (FY)](https://www.tradingview.com/symbols/MYX-PHARMA/financials-income-statement/net-income/) ‪131.82 M‬ MYR [Revenue (FY)](https://www.tradingview.com/symbols/MYX-PHARMA/financials-revenue/) ‪3.76 B‬ MYR [Shares float](https://www.tradingview.com/symbols/MYX-PHARMA/financials-statistics-and-ratios/float-shares-outstanding/) ‪3.02 B‬ Beta (1Y) 2\.74 [Employees ](https://www.tradingview.com/symbols/MYX-PHARMA/financials-statistics-and-ratios/number-of-employees/) Employees (FY) ‪3.5 K‬ Change (1Y) \+26 +0.75% Revenue / Employee (1Y) ‪1.07 M‬ MYR Net income / Employee (1Y) ‪37.64 K‬ MYR ## About Pharmaniaga Bhd. Sector [Distribution Services](https://www.tradingview.com/markets/stocks-malaysia/sectorandindustry-sector/distribution-services/) Industry [Medical Distributors](https://www.tradingview.com/markets/stocks-malaysia/sectorandindustry-industry/medical-distributors/) CEO Zulkifli bin Jafar Website [pharmaniaga.com](http://www.pharmaniaga.com/) Headquarters Shah Alam Founded 1994 Identifiers 2 ISIN MYL7081OO002 Pharmaniaga Bhd. is as an investment holding company that engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. It operates through the following segments: Pharmaceutical Manufacturing, Pharmaceutical Trading, Marketing Distribution and E-Services, Medical Products and Services, and Others. The Pharmaceutical Manufacturing segment engages in manufacturing of pharmaceutical products. The Marketing Distribution and E-Services segment engages in purchasing, storage, distribution and marketing of pharmaceutical and medical products. The Medical Products and Services segment engages in supply and installation of medical and hospital equipment. The Others segment engages in investment holding. The company was founded in 1994 and is headquartered in Shah Alam, Malaysia. Show more [Financials ](https://www.tradingview.com/symbols/MYX-PHARMA/financials-overview/) Performance AnnualAnnual QuarterlyQuarterly More More ‪0.25%‬ ‪2.75%‬ ‪5.25%‬ ‪7.75%‬ ‪10.25%‬ Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 ‪0.00‬ ‪‪300.00 M‬‬ ‪‪600.00 M‬‬ ‪‪900.00 M‬‬ ‪‪1.20 B‬‬ Revenue Net income Net margin % Revenue to profit conversion AnnualAnnual QuarterlyQuarterly More More Revenue COGS Gross profit Op expenses Op income Non-Op income/ expenses Taxes & Other Net income ‪0.00‬ ‪‪260.00 M‬‬ ‪‪520.00 M‬‬ ‪‪780.00 M‬‬ ‪‪1.04 B‬‬ Revenue COGS Gross profit Expenses & adjustments Net income ‪0.00‬ ‪‪260.00 M‬‬ ‪‪520.00 M‬‬ ‪‪780.00 M‬‬ ‪‪1.04 B‬‬ Debt level and coverage AnnualAnnual QuarterlyQuarterly More More Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 ‪‪−450.00 M‬‬ ‪0.00‬ ‪‪450.00 M‬‬ ‪‪900.00 M‬‬ ‪‪1.35 B‬‬ Debt Free cash flow Cash & equivalents Earnings Next:Feb 26, 2026 AnnualAnnual QuarterlyQuarterly More More Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 ‪0.00‬ ‪0.00‬ ‪0.00‬ ‪0.00‬ ‪0.00‬ Actual [News ](https://www.tradingview.com/symbols/MYX-PHARMA/news/) No news here Looks like there's nothing to report right now [Reload](https://www.tradingview.com/symbols/MYX-PHARMA/) [Ideas ](https://www.tradingview.com/symbols/MYX-PHARMA/ideas/) [NAKED CHART / PVA / BULL CS](https://www.tradingview.com/chart/PHARMA/aKl44cVx-NAKED-CHART-PVA-BULL-CS/) [PREDICT PRICE DIRECTION ONLY pva bull cs chart pattern](https://www.tradingview.com/chart/PHARMA/aKl44cVx-NAKED-CHART-PVA-BULL-CS/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") [![](https://s3.tradingview.com/a/aKl44cVx_mid.png)](https://www.tradingview.com/chart/PHARMA/aKl44cVx-NAKED-CHART-PVA-BULL-CS/) [by habb288](https://www.tradingview.com/u/habb288/) Dec 21, 2025 0 [PREDICT PRICE DIRECTION ONLY........TFW](https://www.tradingview.com/chart/PHARMA/Myvaovc5-PREDICT-PRICE-DIRECTION-ONLY-TFW/)[Predict price will break zone /R / box with volume will test Resistance / TP TARGET duration monitoring - 2 to 4 weeks TFW - Top Volume momentum stock Risk - penny stock](https://www.tradingview.com/chart/PHARMA/Myvaovc5-PREDICT-PRICE-DIRECTION-ONLY-TFW/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") [![](https://s3.tradingview.com/m/Myvaovc5_mid.png)](https://www.tradingview.com/chart/PHARMA/Myvaovc5-PREDICT-PRICE-DIRECTION-ONLY-TFW/) [by habb288](https://www.tradingview.com/u/habb288/) Nov 15, 2025 0 [PREDICT PRICE DIRECTION ONLY](https://www.tradingview.com/chart/PHARMA/RkeRzmhj-PREDICT-PRICE-DIRECTION-ONLY/)[Predict price will break zone /R / box with volume will test Resistance / TP TARGET duration monitoring - 2 to 4 weeks TFW - Top Volume momentum stock Risk - penny stock](https://www.tradingview.com/chart/PHARMA/RkeRzmhj-PREDICT-PRICE-DIRECTION-ONLY/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") [![](https://s3.tradingview.com/r/RkeRzmhj_mid.png)](https://www.tradingview.com/chart/PHARMA/RkeRzmhj-PREDICT-PRICE-DIRECTION-ONLY/) [by habb288](https://www.tradingview.com/u/habb288/) Nov 13, 2025 0 [PHARMANIAGA - Uptrend remains intact](https://www.tradingview.com/chart/PHARMA/cqLjnZ0Z-PHARMANIAGA-Uptrend-remains-intact/)[Uptrend remains intact — price is respecting a higher-low trajectory drawn from late July towards October. Currently, price seems to be consolidating just above the trendline, which acts as a short-term dynamic support. The consolidation phase looks healthy, suggesting accumulation rather than dist](https://www.tradingview.com/chart/PHARMA/cqLjnZ0Z-PHARMANIAGA-Uptrend-remains-intact/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") [![](https://s3.tradingview.com/c/cqLjnZ0Z_mid.png)](https://www.tradingview.com/chart/PHARMA/cqLjnZ0Z-PHARMANIAGA-Uptrend-remains-intact/) [by CyphuellAzm](https://www.tradingview.com/u/CyphuellAzm/) Oct 8, 2025 1 [IDEA PREDICT PRICE DIRECTION ONLY](https://www.tradingview.com/chart/PHARMA/CSrEYrYp-IDEA-PREDICT-PRICE-DIRECTION-ONLY/)[predict trend - uptrend cs - bull cs duration monitoring - 2 to 4 weeks](https://www.tradingview.com/chart/PHARMA/CSrEYrYp-IDEA-PREDICT-PRICE-DIRECTION-ONLY/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") [![](https://s3.tradingview.com/c/CSrEYrYp_mid.png)](https://www.tradingview.com/chart/PHARMA/CSrEYrYp-IDEA-PREDICT-PRICE-DIRECTION-ONLY/) [by habb288](https://www.tradingview.com/u/habb288/) Sep 18, 2025 4 [PREDICT PRICE DIRECTION ONLY](https://www.tradingview.com/chart/PHARMA/WXWEqdUI-PREDICT-PRICE-DIRECTION-ONLY/)[Predict trend : uptrend duration monitoring : 2 - 4 weeks](https://www.tradingview.com/chart/PHARMA/WXWEqdUI-PREDICT-PRICE-DIRECTION-ONLY/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") [![](https://s3.tradingview.com/w/WXWEqdUI_mid.png)](https://www.tradingview.com/chart/PHARMA/WXWEqdUI-PREDICT-PRICE-DIRECTION-ONLY/) [by habb288](https://www.tradingview.com/u/habb288/) Sep 14, 2025 0 [PHARMA: LONG JOURNEY TO EXIT PN17](https://www.tradingview.com/chart/PHARMA/xS5vQ3lI-PHARMA-LONG-JOURNEY-TO-EXIT-PN17/)[The company takes time to recover. Hope turns well](https://www.tradingview.com/chart/PHARMA/xS5vQ3lI-PHARMA-LONG-JOURNEY-TO-EXIT-PN17/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") [![](https://s3.tradingview.com/x/xS5vQ3lI_mid.png)](https://www.tradingview.com/chart/PHARMA/xS5vQ3lI-PHARMA-LONG-JOURNEY-TO-EXIT-PN17/) [by RAR-BSJ](https://www.tradingview.com/u/RAR-BSJ/) Jun 25, 2025 0 [PHARMA - Looking for bullish movement](https://www.tradingview.com/chart/PHARMA/fm7Wy8TE-PHARMA-Looking-for-bullish-movement/)[N wave with E, N & NT projection. The stock has recently broken above a significant downtrend line, signaling a potential trend reversal from a prolonged downtrend. It also recently moved above the Kumo, confirming bullish momentum. Pullback after the wave B peak around 0.32, currently consolidating](https://www.tradingview.com/chart/PHARMA/fm7Wy8TE-PHARMA-Looking-for-bullish-movement/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") Long [![](https://s3.tradingview.com/f/fm7Wy8TE_mid.png)](https://www.tradingview.com/chart/PHARMA/fm7Wy8TE-PHARMA-Looking-for-bullish-movement/) [by mg6112](https://www.tradingview.com/u/mg6112/) May 18, 2025 0 [Pharma Triple Top Pattern](https://www.tradingview.com/chart/PHARMA/Mi9UtlC1-Pharma-Triple-Top-Pattern/)[Pharma, a company engange in research and developing medical drug and devices was a darling in pharmaceutical in Malaysia. Recently, it had been hit hard with expired vaccine and the obsolete of PPE, needles etc (for Covid 19 use) impairment which was not utilised by the MOF. The recovery of](https://www.tradingview.com/chart/PHARMA/Mi9UtlC1-Pharma-Triple-Top-Pattern/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") Short [![](https://s3.tradingview.com/m/Mi9UtlC1_mid.png)](https://www.tradingview.com/chart/PHARMA/Mi9UtlC1-Pharma-Triple-Top-Pattern/) [by K\_S\_AbdHamid](https://www.tradingview.com/u/K_S_AbdHamid/) Feb 11, 2024 [22](https://www.tradingview.com/chart/PHARMA/Mi9UtlC1-Pharma-Triple-Top-Pattern/#chart-view-comment-form "Comment") 0 [Pharma, catching my attention](https://www.tradingview.com/chart/PHARMA/aURR4naL-Pharma-catching-my-attention/)[After 2 weeks of rebounding from the bottom, it has come to the weekly trendline resistance at 0.425sen. Obviously it is not the right timing to enter as it will retrace anytime from the resistance line. Hence, the surge of price does not supported with volume. I will wait for the higher low form](https://www.tradingview.com/chart/PHARMA/aURR4naL-Pharma-catching-my-attention/) [M](https://www.tradingview.com/symbols/MYX-PHARMA/ "MYX:PHARMA") [![](https://s3.tradingview.com/a/aURR4naL_mid.png)](https://www.tradingview.com/chart/PHARMA/aURR4naL-Pharma-catching-my-attention/) [by JeremyTee\_ws](https://www.tradingview.com/u/JeremyTee_ws/) Dec 18, 2023 1 [See all ideas](https://www.tradingview.com/symbols/MYX-PHARMA/ideas/) [Technicals ](https://www.tradingview.com/symbols/MYX-PHARMA/technicals/) Summarizing what the indicators are suggesting. Neutral SellBuy Strong sellStrong buy Strong sellSellNeutralBuyStrong buy Neutral SellBuy Strong sellStrong buy Strong sellSellNeutralBuyStrong buy Neutral SellBuy Strong sellStrong buy Strong sellSellNeutralBuyStrong buy [Analyst rating ](https://www.tradingview.com/symbols/MYX-PHARMA/forecast/) An aggregate view of professional's ratings. Neutral SellBuy Strong sellStrong buy Strong sellSellNeutralBuyStrong buy Neutral SellBuy Strong sellStrong buy Strong sellSellNeutralBuyStrong buy Neutral SellBuy Strong sellStrong buy Strong sellSellNeutralBuyStrong buy [Seasonals ](https://www.tradingview.com/symbols/MYX-PHARMA/seasonals/) Displays a symbol's price movements over previous years to identify recurring trends. ## Frequently Asked Questions What is Pharmaniaga Bhd. stock price today? The current price of PHARMA is 0.290 MYR — it has decreased by −1.69% in the past 24 hours. Watch Pharmaniaga Bhd. stock price performance more closely on the [chart](https://www.tradingview.com/chart/?symbol=MYX:PHARMA). What is Pharmaniaga Bhd. stock ticker? Depending on the exchange, the stock ticker may vary. For instance, on MYX exchange Pharmaniaga Bhd. stocks are traded under the ticker PHARMA. Is Pharmaniaga Bhd. stock price growing? PHARMA stock has risen by 3.51% compared to the previous week, the month change is a 11.32% rise, over the last year Pharmaniaga Bhd. has showed a 47.82% increase. What is PHARMA stock forecast? We've gathered analysts' opinions on Pharmaniaga Bhd. future price: according to them, PHARMA price has a max estimate of 0.29 MYR and a min estimate of 0.15 MYR. Watch [PHARMA chart](https://www.tradingview.com/chart/?symbol=MYX:PHARMA) and read a more detailed [Pharmaniaga Bhd. stock forecast](https://www.tradingview.com/symbols/MYX-PHARMA/forecast/): see what analysts think of Pharmaniaga Bhd. and suggest that you do with its stocks. What are Pharmaniaga Bhd. stock highest and lowest prices ever? PHARMA reached its all-time high on Apr 28, 2015 with the price of 0.895 MYR, and its all-time low was 0.110 MYR and was reached on Mar 23, 2020. View more price dynamics on [PHARMA chart](https://www.tradingview.com/chart/?symbol=MYX:PHARMA). See other stocks reaching their [highest](https://www.tradingview.com/markets/stocks-malaysia/market-movers-ath/) and [lowest](https://www.tradingview.com/markets/stocks-malaysia/market-movers-atl/) prices. How volatile is PHARMA stock? PHARMA stock is 1.72% volatile and has beta coefficient of 2.72. Track Pharmaniaga Bhd. stock price on the [chart](https://www.tradingview.com/chart/?symbol=MYX:PHARMA) and check out the list of the [most volatile stocks](https://www.tradingview.com/markets/stocks-malaysia/market-movers-most-volatile/) — is Pharmaniaga Bhd. there? What is Pharmaniaga Bhd. market cap? Today Pharmaniaga Bhd. has the market capitalization of ‪1.93 B‬, it has increased by 1.79% over the last week. Does Pharmaniaga Bhd. release reports? Yes, you can track [Pharmaniaga Bhd. financials](https://www.tradingview.com/symbols/MYX-PHARMA/financials-income-statement/) in yearly and quarterly reports right on TradingView. When is the next Pharmaniaga Bhd. earnings date? Pharmaniaga Bhd. is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our [Earnings Calendar](https://www.tradingview.com/markets/stocks-malaysia/earnings/). What is PHARMA net income for the last quarter? PHARMA net income for the last quarter is ‪7.28 M‬ MYR, while the quarter before that showed ‪3.96 M‬ MYR of net income which accounts for 83.74% change. Track more [Pharmaniaga Bhd. financial stats](https://www.tradingview.com/symbols/MYX-PHARMA/financials-income-statement/) to get the full picture. How many employees does Pharmaniaga Bhd. have? As of Jan 19, 2026, the company has ‪3.5 K‬ employees. See our rating of the [largest employees](https://www.tradingview.com/markets/stocks-malaysia/market-movers-largest-employers/) — is Pharmaniaga Bhd. on this list? What is Pharmaniaga Bhd. EBITDA? EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharmaniaga Bhd. EBITDA is ‪178.72 M‬ MYR, and current EBITDA margin is 8.16%. See more stats in [Pharmaniaga Bhd. financial statements](https://www.tradingview.com/symbols/MYX-PHARMA/financials-income-statement/). How to buy Pharmaniaga Bhd. stocks? Like other stocks, PHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharmaniaga Bhd. stock right from TradingView charts — choose your [broker](https://www.tradingview.com/brokers/) and connect to your account. Should I invest in Pharmaniaga Bhd. stock? Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharmaniaga Bhd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharmaniaga Bhd. stock shows the buy signal. See more of [Pharmaniaga Bhd. technicals](https://www.tradingview.com/symbols/MYX-PHARMA/technicals/) for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our [curated watchlists](https://www.tradingview.com/sparks/). *** EnglishEnglish Select market data provided by [ICE Data Services](https://www.theice.com/market-data). Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC fillings and other documents provided by [Quartr](https://www.quartr.com/).© 2026 TradingView, Inc. More than a product - [Supercharts](https://www.tradingview.com/chart/) Screeners - [Stocks](https://www.tradingview.com/screener/) - [ETFs](https://www.tradingview.com/etf-screener/) - [Bonds](https://www.tradingview.com/bond-screener/) - [Crypto coins](https://www.tradingview.com/crypto-coins-screener/) - [CEX pairs](https://www.tradingview.com/cex-screener/) - [DEX pairs](https://www.tradingview.com/dex-screener/) - [Pine](https://www.tradingview.com/pine-screener/) Heatmaps - [Stocks](https://www.tradingview.com/heatmap/stock/) - [ETFs](https://www.tradingview.com/heatmap/etf/) - [Crypto](https://www.tradingview.com/heatmap/crypto/) Calendars - [Economic](https://www.tradingview.com/economic-calendar/) - [Earnings](https://www.tradingview.com/earnings-calendar/) - [Dividends](https://www.tradingview.com/dividend-calendar/) More products - [Yield Curves](https://www.tradingview.com/yield-curves/) - [Options](https://www.tradingview.com/options/) - [News Flow](https://www.tradingview.com/news-flow/) - [Pine Script®](https://www.tradingview.com/pine-script-docs/) Apps - [Mobile](https://www.tradingview.com/mobile/) - [Desktop](https://www.tradingview.com/desktop/) Community - [Social network](https://www.tradingview.com/social-network/) - [Wall of Love](https://www.tradingview.com/wall-of-love/) - [Refer a friend](https://www.tradingview.com/share-your-love/?source=footer&feature=refer_friend) - [House Rules](https://www.tradingview.com/house-rules/) - [Moderators](https://www.tradingview.com/moderators/) Ideas - [Trading](https://www.tradingview.com/ideas/) - [Education](https://www.tradingview.com/ideas/?type=education) - [Editors' picks](https://www.tradingview.com/ideas/editors-picks/) Pine Script - [Indicators & strategies](https://www.tradingview.com/scripts/) - [Wizards](https://www.tradingview.com/pine-wizards/) - [Freelancers](https://www.tradingview.com/pine-script-freelancers/) Tools & subscriptions - [Features](https://www.tradingview.com/features/) - [Pricing](https://www.tradingview.com/pricing/?source=footer&feature=pricing) - [Market data](https://www.tradingview.com/data-coverage/) - [Gift plans](https://www.tradingview.com/gifts/) Trading - [Overview](https://www.tradingview.com/trading/) - [Brokers](https://www.tradingview.com/brokers/) Special offers - [CME Group futures](https://www.tradingview.com/cme/) - [Eurex futures](https://www.tradingview.com/eurex/) - [US stocks bundle](https://www.tradingview.com/us-markets-bundle/) About company - [Who we are](https://www.tradingview.com/about/) - [Space mission](https://www.tradingview.com/space-mission/) - [Blog](https://www.tradingview.com/blog/en/) - [Careers](https://www.tradingview.com/careers/) - [Media kit](https://www.tradingview.com/media-kit/) Merch - [TradingView store](https://tradingviewstore.com/) - [Tarot cards for traders](https://www.tradingview.com/tarot-reading/) - [The C63 TradeTime](https://www.tradingview.com/tradetime/) Policies & security - [Terms of Use](https://www.tradingview.com/policies/) - [Disclaimer](https://www.tradingview.com/disclaimer/) - [Privacy Policy](https://www.tradingview.com/privacy-policy/) - [Cookies Policy](https://www.tradingview.com/cookies-policy/) - [Accessibility Statement](https://www.tradingview.com/accessibility/) - [Security tips](https://www.tradingview.com/security/) - [Bug Bounty program](https://www.tradingview.com/bounty/) - [Status page](https://status.tradingview.com/) Business solutions - [Widgets](https://www.tradingview.com/widget/) - [Charting libraries](https://www.tradingview.com/free-charting-libraries/) - [Lightweight Charts™](https://www.tradingview.com/lightweight-charts/) - [Advanced Charts](https://www.tradingview.com/advanced-charts/) - [Trading Platform](https://www.tradingview.com/trading-platform/) Growth opportunities - [Advertising](https://www.tradingview.com/advertising-info/) - [Brokerage integration](https://www.tradingview.com/brokerage-integration/) - [Partner program](https://www.tradingview.com/partner-program/) - [Education program](https://www.tradingview.com/students/) Community - [Social network](https://www.tradingview.com/social-network/) - [Wall of Love](https://www.tradingview.com/wall-of-love/) - [Refer a friend](https://www.tradingview.com/share-your-love/?source=footer&feature=refer_friend) - [House Rules](https://www.tradingview.com/house-rules/) - [Moderators](https://www.tradingview.com/moderators/) Ideas - [Trading](https://www.tradingview.com/ideas/) - [Education](https://www.tradingview.com/ideas/?type=education) - [Editors' picks](https://www.tradingview.com/ideas/editors-picks/) Pine Script - [Indicators & strategies](https://www.tradingview.com/scripts/) - [Wizards](https://www.tradingview.com/pine-wizards/) - [Freelancers](https://www.tradingview.com/pine-script-freelancers/) Business solutions - [Widgets](https://www.tradingview.com/widget/) - [Charting libraries](https://www.tradingview.com/free-charting-libraries/) - [Lightweight Charts™](https://www.tradingview.com/lightweight-charts/) - [Advanced Charts](https://www.tradingview.com/advanced-charts/) - [Trading Platform](https://www.tradingview.com/trading-platform/) Growth opportunities - [Advertising](https://www.tradingview.com/advertising-info/) - [Brokerage integration](https://www.tradingview.com/brokerage-integration/) - [Partner program](https://www.tradingview.com/partner-program/) - [Education program](https://www.tradingview.com/students/) ![Look First](https://static.tradingview.com/static/bundles/look-first-dark.8cb7462c584f600e8f31.svg)![Look First](https://static.tradingview.com/static/bundles/look-first-light.74b5bba06f657157cdb4.svg) Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more Show more
Readable Markdown	null
Shard	78 (laksa)
Root Hash	6550570140545720678
Unparsed URL	com,tradingview!www,/symbols/MYX-PHARMA/ s443